Acquired hemophilia in a 7-year-old girl successfully treated with recombinant FVIIA and steroids: A case report
- PMID: 33598217
- PMCID: PMC7869384
- DOI: 10.1002/ccr3.3588
Acquired hemophilia in a 7-year-old girl successfully treated with recombinant FVIIA and steroids: A case report
Abstract
Acquired hemophilia should be evaluated in pediatric patients with bleeding and isolated prolonged aPTT. Immunosuppressive treatment should be initiated even in minor bleedings. Bypassing agents like rFVIIa can be used in children with success.
Keywords: Acquired hemophilia A; factor VIII deficiency; pediatric population; recombinant factor VII activated.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors stated that they had no interests that might be perceived as posing a conflict or bias.
Figures
References
-
- Franchini M, Zaffanello M, Lippi G. Acquired hemophilia in pediatrics: A systematic review. Pediatr Blood Cancer. 2010;55(4):606‐611. - PubMed
-
- Kruse‐Jarres R, Kempton CL, Baudo F, et al. Acquired hemophilia A: Updated review of evidence and treatment guidance. Am J Hematol. 2017;92(7):695‐705. - PubMed
-
- Collins PW. Management of acquired haemophilia A. J Thromb Haemost. 2011;9:226‐235. - PubMed
-
- Baudo F, Collins P, Huth‐Kühne A, et al. Management of bleeding in acquired hemophilia A: Results from the European Acquired Haemophilia (EACH2) registry. Blood. 2012;120(1):39‐46. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
